Dosages; See below
Combinations; See below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ltd. | Ltd | mg | 30 | Tablet | per tablet | KES | |
| Ltd | (K) Ltd. | mg | 30 | Tablet | per tablet | KES |
| Oxybutynin More info | |
|---|---|
| Mode Of Action | Flavoxate and oxybutynin have direct antispasmodic effects on smooth muscle, especially of the urinary tract. They also have weak antihistaminic effect, local anaesthetic, analgesic and weak anticholinergic properties at higher doses. |
| Drug Indication | Urinary frequency and incontinence dysuria; urgency and bladder spasms due to catheterization; nocturnal enuresis |
| Precautions | Myasthenia gravis; renal and hepatic impairment; pregnancy and lactation; elderly; diarrhoea; glaucoma; hypertension; ulcerative colitis; Down syndrome |
| Contra-Indications | Prostate enlargement; paralytic ileus; pyloric stenosis; high ambient temperatures |
| Side Effects | Anticholinergic SE: dry mouth /skin; difficult in swallowing; visual disturbances; flushings; constipation; difficult in micturation. Drowsiness; arrhythmias |
| Dosage | Adults: 2.5-5.0mg BD or TID initially, then increased daily to a max. of 5mg QID. For elderly: 2.5-3.0mg BD initially, then increased daily to a max. of 5mg BD. For children: 2.5-3.0mg BD initially, then increased daily to a max. of 5mg TID). |
| Special Information | Its causes more side effects than flavoxate though it is more effective. |
| Drug Category | DRUGS ACTING ON GENITO-URINARY SYSTEM |
| Drug Sub-Category | Other genito-urinary acting drugs |